Accéder au contenu
Merck

The effects of perinatal testosterone exposure on the DNA methylome of the mouse brain are late-emerging.

Biology of sex differences (2014-07-01)
Negar M Ghahramani, Tuck C Ngun, Pao-Yang Chen, Yuan Tian, Sangitha Krishnan, Stephanie Muir, Liudmilla Rubbi, Arthur P Arnold, Geert J de Vries, Nancy G Forger, Matteo Pellegrini, Eric Vilain
RÉSUMÉ

The biological basis for sex differences in brain function and disease susceptibility is poorly understood. Examining the role of gonadal hormones in brain sexual differentiation may provide important information about sex differences in neural health and development. Permanent masculinization of brain structure, function, and disease is induced by testosterone prenatally in males, but the possible mediation of these effects by long-term changes in the epigenome is poorly understood. We investigated the organizational effects of testosterone on the DNA methylome and transcriptome in two sexually dimorphic forebrain regions-the bed nucleus of the stria terminalis/preoptic area and the striatum. To study the contribution of testosterone to both the establishment and persistence of sex differences in DNA methylation, we performed genome-wide surveys in male, female, and female mice given testosterone on the day of birth. Methylation was assessed during the perinatal window for testosterone's organizational effects and in adulthood. The short-term effect of testosterone exposure was relatively modest. However, in adult animals the number of genes whose methylation was altered had increased by 20-fold. Furthermore, we found that in adulthood, methylation at a substantial number of sexually dimorphic CpG sites was masculinized in response to neonatal testosterone exposure. Consistent with this, testosterone's effect on gene expression in the striatum was more apparent in adulthood. Taken together, our data imply that the organizational effects of testosterone on the brain methylome and transcriptome are dramatic and late-emerging. Our findings offer important insights into the long-term molecular effects of early-life hormonal exposure.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Fluorescein, for fluorescence, free acid
Sigma-Aldrich
Testosterone, purum, ≥99.0% (HPLC)
Sigma-Aldrich
Testosterone, ≥98%
Supelco
Testosterone solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Testosterone propionate, solid
Fluorescein, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Testosterone propionate, tested according to Ph. Eur.
Supelco
Testosterone, VETRANAL®, analytical standard
Testosterone, European Pharmacopoeia (EP) Reference Standard
Testosterone propionate, European Pharmacopoeia (EP) Reference Standard
Testosterone propionate, European Pharmacopoeia (EP) Reference Standard